What we do Fabino Enterprises Ltd manufactures and markets pharmaceutical and FMCG products in India and overseas, focusing on allopathic, herbal medicines, and wellness goods under Fabino and Keepshine brands. |
Founded in 2,011 |
Market share Active in domestic pharmaceutical markets and select FMCG overseas markets with growing IP and export reach to 12+ Indian states and multiple countries including Nepal. |
Problem solved Provides accessible medicines and wellness products catering to allopathic and herbal health needs, along with FMCG wellness solutions. |
Top clients or who we serve Domestic hospitals, medical institutions, retail pharmacies, and export clients in FMCG sectors; primarily B2B and B2C channels. |
Key management - |
Our journey and innovations Founded in 2011, converted to public in 2015; expanded from pharma formulations to herbal, ayurvedic, and FMCG products, launched own brands and secured patents. |
Where we operate India covering Haryana, Delhi, Punjab, Himachal Pradesh, Uttar Pradesh, Odisha, Jharkhand, West Bengal, Andhra Pradesh, and export to Nepal and other overseas FMCG markets. |
Top products or what we offer Pharmaceuticals (tablets, syrups, ointments), herbal and ayurvedic products, FMCG wellness items like coffee, protein powders, shampoos under Fabino and Keepshine brands. |
Top brands Fabino: pharmaceutical formulations (tablets, capsules, syrups); Keepshine: hair care shampoos and maintenance products. |
Raw materials needed Pharmaceutical raw materials including vitamins, organic compounds for tablets, syrups, herbal extracts for ayurvedic products. |
Raw materials supplier Primarily third-party manufacturers and contract facilities in Haryana supplying formulations and packaging. |
Recurring vs cyclical contribution Revenue mainly from recurring sales through distribution network with some cyclical variation in contract manufacturing orders. |
Our industry position Growing pharmaceutical and FMCG player with robust distribution in North and East India, increasing intellectual property footprint. |
Financial highlights Standalone revenue Rs. 18.32 crore FY25, net profit Rs. 0.13 crore FY25, showing significant growth from previous year. |
Geographical revenue split Predominantly North and East India with exports in FMCG to overseas markets including Nepal. |
Order book - |
Whats driving growth Expansion of product portfolio, increased domestic distribution, new herbal manufacturing division, and international FMCG exports. |
Our future plans Diversify into food processing and agriculture-based products, enhance herbal and ayurvedic manufacturing capabilities. |
Our green promise - |
Our people and values Employs 19 people promoting diversity and a culture of quality and regulatory compliance. |
Key challenges ahead Managing competition, scaling manufacturing, regulatory compliance, and sustaining growth in a competitive pharma and FMCG market. |
Interesting facts Holds patents and certifications including ISO 9001:2015 and GMP for Ayurvedic products; publicly listed since 2022. |
Risks and strategy Focus on strict quality controls, diversified product base, and building strong brand presence to mitigate market and operational risks. |
